Dexmedetomidine-esketamine combination
2023-276
Unknown small_molecule completed
Quick answer
Dexmedetomidine-esketamine combination for Liver Cancer is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Liver Cancer
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed